{"organizations": [], "uuid": "bccdc0e3c83a5dba426f78ba1675554e11319310", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-eleven-biotherapeutics-announces-p/brief-eleven-biotherapeutics-announces-pricing-of-10-0-million-offering-priced-at-the-market-idUSASC09T6F", "country": "US", "domain_rank": 408, "title": "BRIEF-Eleven Biotherapeutics Announces Pricing Of $10.0 Million Offering Priced At-The-Market", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-21T15:38:00.000+02:00", "replies_count": 0, "uuid": "bccdc0e3c83a5dba426f78ba1675554e11319310"}, "author": "", "url": "https://www.reuters.com/article/brief-eleven-biotherapeutics-announces-p/brief-eleven-biotherapeutics-announces-pricing-of-10-0-million-offering-priced-at-the-market-idUSASC09T6F", "ord_in_thread": 0, "title": "BRIEF-Eleven Biotherapeutics Announces Pricing Of $10.0 Million Offering Priced At-The-Market", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-eleven biotherapeutics", "sentiment": "negative"}, {"name": "reuters staff eleven biotherapeutics inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 21, 2018 / 1:41 PM / Updated 26 minutes ago BRIEF-Eleven Biotherapeutics Announces Pricing Of $10.0 Million Offering Priced At-The-Market Reuters Staff Eleven Biotherapeutics Inc: * ELEVEN BIOTHERAPEUTICS ANNOUNCES PRICING OF $10.0 MILLION OFFERING PRICED AT-THE-MARKET * ELEVEN BIOTHERAPEUTICS - ENTERED DEFINITIVE AGREEMENT WITH SEVERAL INVESTORS FOR PURCHASE OF ABOUT 8 MILLION SHARES OF ITS COMMON STOCK AT $1.13PER SHARE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-21T15:38:00.000+02:00", "crawled": "2018-03-21T16:20:15.087+02:00", "highlightTitle": ""}